Elevations in thyroid-stimulating hormone in normal subjects after receiving short-term lithium carbonate

Drug Intell Clin Pharm. 1988 Mar;22(3):202-4. doi: 10.1177/106002808802200304.

Abstract

Nine normal, healthy male subjects had significantly elevated thyroid-stimulating hormone (TSH) concentrations while receiving oral lithium carbonate for two weeks. The mean minimum lithium serum concentration was 0.765 mEq/L. The TSH concentrations after 15 days on lithium were significantly correlated to the TSH concentration at baseline. No correlation was found between mean minimum lithium steady-state concentration and TSH concentration after 15 days on lithium. Further research is necessary to determine if a high baseline TSH concentration or an early rise in TSH will predict those patients who will eventually develop hypothyroidism after long-term lithium therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Humans
  • Lithium / adverse effects*
  • Lithium Carbonate
  • Male
  • Thyrotropin / blood*
  • Time Factors

Substances

  • Lithium Carbonate
  • Thyrotropin
  • Lithium